600 patients66,869 observations120 daysLIVE

Patient P-01623

Synthetic patientNBL-101 · Day 109 · 75+ · F · baseline S16Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Unstable
Inflammatory state
Improving
Nutritional resilience
Unstable
Discontinuation risk
56%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S16
  2. Day 82 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 82.

Primary contributors, last 14 days
  • Treatment adherence-12
  • Inflammatory activity-9
  • Toxicity-8
  • Nutritional resilience-5

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    58%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 83% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    60.6/100
    worsening · +9.1 vs previous 14 d
    Toxicity
    Blood
    49/100
    worsening · +6.2 vs previous 14 d
    Sleep quality
    Wearable
    23.9/100
    worsening · -1.8 vs previous 14 d
    Energy level
    Daily log
    2.9/10
    worsening · -0.9 vs previous 14 d
    Stress level
    Daily log
    8.1/10
    worsening · +0.7 vs previous 14 d
    Steps
    Wearable
    7,697
    stable · -110 vs previous 14 d
    Adherence
    Companion
    67 %
    worsening · -17.0 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 33 from the failing basin, 59 from restoration.

    Good elements to keep
    • Daily walks resumed
      perturbation · steering +3.3
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • FUT2 non-secretor
      hidden · steering -10.6
    • Dietary fat load
      perturbation · steering -9.2
    • Low microbial diversity
      hidden · steering -7.7
    • Dietary fat load
      detractor · GI +4.9 next day
    • Histamine load
      detractor · GI +3.5 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Dietary fat load
      +4.9detractor · 95%
    • Histamine load
      +3.5detractor · 95%
    • Simple carbohydrates
      +2.1detractor · 74%
    • Alcohol
      +2no signal · 54%
    • Insoluble fibre
      +1.4no signal · 40%
    • Spicy / capsaicin
      +0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 90
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 61 and rising
      • WearableSleep 6.1 h, below personal baseline
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 38/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Inflammatory signalling 65
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • BloodInflammatory load index 54
      • WearableHRV 21 ms, trending down
    • Drug metabolism and exposure 20
      • BloodToxicity index 49
    • Autonomic recovery 20
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.1 · butyrate capacity 38/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    19 ms
    Sleep
    6.0 h
    Steps
    7,444
    Resting HR
    71 bpm
    Daily log: GI score 61, nutritional resilience 36, adherence 67.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0183551%S17CR-01improved56
    P-0138846%S17CR-01improved59
    P-0169644%S20CR-01improved59
    P-0187743%S01CR-01improved67
    P-0169940%S04GI-04improved69
    P-0137139%S06CR-01improved63
    P-0170839%S07CR-01improved59
    P-0144238%S13CR-01improved61
    P-0134937%S14GI-04improved38
    P-0133636%S03GI-04improved51
    P-0139336%S14GI-04improved53
    P-0143336%S14GI-04improved48